A recent study suggests that risk-taking decreases with age and that this may be related to dopaminemodulated changes in Pavlovian approach behavior, and not a reduction in the subjective value of incremental rewards as traditional models from economics and psychology would have claimed.
In economics and psychology, a choice between gambles, or between a gamble and a sure bet, is thought to be made on the basis of the difference in subjective values between the available options. The subjective value of a gamble is determined by the average of the subjective values (or utilities in economics) of the possible outcomes that the gamble may generate. Risk sensitivity emerges when a subjective value does not increase linearly with the outcomes.
Specifically, if an incremental subjective value (marginal utility) decreases with the size of the outcome, a lower subjective value will be assigned to a gamble than to an option that promises for sure the average payoff of the gamble ( Figure 1A ). In this framework, a change in risk-taking, for example over a life-cycle, would be attributed to a change in incremental subjective value of gains or losses. In this issue of Current Biology, Rutledge et al. [1] report findings suggesting that this picture of risk-taking is incomplete.
Using a large, cross-sectional sample from the general population, the authors demonstrate that there is a decline in risk-taking with age which is related to decreased Pavlovian approach behaviour, and not to a decrease in the marginal subjective value of gains. Their findings have major implications for our understanding of risk-taking and the neurobiological mechanisms underlying it.
In recent prior work, Rutledge et al. [2] demonstrated that an important component is missing in existing, subjective value-based models of risk-taking, namely, Pavlovian approach: this latter refers to the propensity of an individual to select (approach) the highest reward, independent of marginal subjective value. In the context of uncertainty, it implies that the decision-maker chooses higher rewards over sure outcomes regardless of the risk of the former ( Figure 1B ). The authors also showed that the dopaminergic system was crucially involved in Pavlovian approach (to risky rewards), as follows: when they administered L-DOPA, a dopamine precursor and indirect dopamine receptor agonist, in a standard risk-taking task, they found that participants tended to choose risky rewards more frequently relative to sure rewards, and that this increase was related not to changes in marginal utility, but to increased Pavlovian approach.
The flip side of Pavlovian approach is loss avoidance. This would reveal itself in the tendency for the decisionmaker to steer clear of gambles in the loss domain, even if, on average, losses are smaller than the alternative of a sure loss. It has been suggested, however, that the neurobiology behind Pavlovian loss avoidance may be more complicated (than that of reward approach), involving, at a minimum, opponency between the dopaminergic and serotonergic systems [3] . If this is the case, simple administration of a dopamine agonist would not necessarily change risk-taking in the loss domain. Indeed, consistent with this, Rutledge et al. [2] found no changes in the frequency of acceptance of gambles in the L-DOPA group, neither when outcomes were all in the loss domain (participants could only lose money), nor in the mixed gain-loss treatment (outcomes included both losses and gains).
On the basis of these findings, Rutledge et al. [1] hypothesized that older people would be less likely to engage in risk-taking than young people, but only in the reward domain. This is because aging has been associated with gradual but pervasive declines in different markers of the dopaminergic system [4, 5] , including the binding potential for the pre-synaptic dopamine transporter [6] , D1 and D2 receptor densities in striatum [7, 8] , as well as decreases in D2 and D3 receptor densities in frontal regions [9] . The overall evidence suggests that there are wide-ranging losses in extrastriatal and striatal presynaptic and postsynaptic markers of the DA system [4] . Rutledge et al. [1] expected these age-related declines in the dopaminergic system to be reflected in Pavlovian approach, and hence, lead to an overall lower propensity to choose risky rewards. They did not expect a corresponding shift in risk attitudes in the loss domain, or the mixed gain-loss domain, however.
To test this hypothesis, Rutledge et al. [1] developed a smartphone app to administer a risk-taking task similar to their previous in-laboratory task, to a large sample from the general population (n = 25,189). They found that older people were less likely to choose risky rewards over sure rewards, but there was no difference in choices that involved only losses or mixed outcomes. The authors confirmed that the change in risk attitudes in the gain domain was due to reduced Pavlovian approach, and not to a change in marginal utility of gains. Altogether, their results are consistent with the findings of their previous laboratory experiment [2] .
The study is a wonderful example of the use of new technology to collect a large amount of field data in order to test hypotheses generated by a laboratory experiment. The research program is also an inspiring example of using biological variation (change in dopamine level) to discover new aspects of economic behaviour (Pavlovian approach behaviour) [10] .
Age versus Ageing
While the data reported by Rutledge et al. [1] are consistent with the hypothesis that age-related differences in risk-taking are associated with agerelated dopamine decline, their evidence is not sufficient for a causal effect of ageing on risk-taking via dopamine changes. Due to the cross-sectional nature of the data set, it is not possible to dissociate confounding factors, in particular period and cohort effects (A) Existing frameworks in economics and psychology model risk-taking in terms of subjective values (SV) of choice options. Risk-taking emerges when incremental (marginal) subjective value (or utility in economics) of additional units of reward is decreasing. Suppose a decision-maker is presented with a choice between a gamble that will pay either 2 units of reward or nothing, with equal probability, or a sure payoff of one. Given decreasing marginal subjective value of reward, the incremental subjective value from the second unit of reward is smaller than that from the first. Therefore, the average subjective value of the two possible outcomes in the gamble (0 or 2) is smaller than the subjective value from a sure outcome of 1. Thus, a decision-maker who only took into account subjective values would be expected to choose the sure outcome over the gamble. (B) The probability of choosing the gamble over the sure reward is given by a sigmoid function of the difference between the subjective values of the two options. Higher subjective value of the gamble relative to the sure outcome corresponds to a higher probability of choosing the gamble. Pavlovian approach acts directly on the probability of choosing the gamble, that is, it increases the probability of choosing the gamble independent of the difference in subjective values. The effect is captured by the parameter 'beta'.
(the age-period-cohort identification problem [11] [12] [13] ). Future studies should aim at documenting more tightly a causal relation between ageing, changes in the dopamine system and risk-taking, by employing cohort studies and more carefully controlling for potential confounding factors and sample bias.
If, as previous findings suggest, the reduction in risk-taking with age indeed originates in fundamental changes in the dopaminergic system with age, we expect to also detect cross-sectional effects between risk-taking on the one hand, and markers of the dopaminergic system and related genetic patterns on the other. Interestingly, previous studies looking at the genetic basis of risk-taking found an association with the MAOA-L gene rather than genes related to dopamine receptor density [14] . In addition, the channel through which the MAOA-L gene was associated with risk-taking is different from the one identified by Rutledge et al. [2] . Cross-sectional studies looking specifically at physiological properties of the dopaminergic system, using methods like molecular imaging or optogenetics, possibly in combination with pharmacological methods, could elucidate the biochemical mechanisms that generate the behavioural effects documented in Rutledge et al. [1] . One immediate question that comes to mind concerns the receptor pathways [3] through which age-related dopamine declines affect risk-taking.
A related open question concerns the failure of Rutledge et al. [1] to find any age-related differences in behaviour in the loss domain and in mixed-reward/ loss trials. Admittedly, the (loss) avoidance component of Pavlovian control may be more complicated neurobiologically, with the serotonergic system conjectured to provide opponent forces to the dopaminergic system [3] . Recent evidence suggests that significant age-related decline also occurs in serotonin receptor availability [15] , which would lead one to hypothesize that opponency becomes less pronounced, potentially off-setting any behavioural effect from a less active dopaminergic system. This would be consistent with the findings in Rutledge et al. [2] . Then again, the dopaminergic system is complex, and it interacts with other transmitter systems, not only the serotonergic, but also the cholinergic and noradrenergic systems [3] . The cholinergic system too has been implicated in reward-based decision-making [3] , and markers of the cholinergic system also decline with age [16] , suggesting that a simple choice model based on traditional modelling of subjective value, even if enriched with Pavlovian control, may be incomplete.
Free Lunches
The fact that Rutledge et al. [1] only found an effect in the reward domain, but no effect in the mixed reward/loss domain, is important from an economic perspective. Most decision situations in economics involve both gains and losses, and the same is the case for most health decisions. For example, there are no financial instruments that do not incur potential losses -otherwise they would constitute 'free lunches' [17] . This means that age-related changes in risk-taking may be less of a concern in important domains such as financial investments. Then again, Rutledge et al. [1] clearly show that traditional, subjective value-based models of choice under uncertainty may not be rich enough to capture all mechanisms through which aging affects risktaking: they set an inspiring example of what future research in this area may look like.
